Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Randomized, Placebo-controlled, Double-blind, Parallel Group, Dose-finding Phase 2 Study to Evaluate Efficacy and Safety of BAY2433334 in Patients Following an Acute Non-cardioembolic Ischemic Stroke

NCT04304508 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT04304508
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04304508 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Randomized, Placebo-controlled, Double-blind, Parallel Group, Dose-finding Phase 2 Study to Evaluate Efficacy and Safety of BAY2433334 in Patients Following an Acute Non-cardioembolic Ischemic Stroke
Lead sponsor
Bayer
Phase
Phase 2
Overall status
Completed
Start date
June 15, 2020
Completion date
February 18, 2022
Enrollment
1,808 (actual)
Sites
197

Conditions

As the registry lists them; a condition with its own page is linked.

acute non-cardioembolic ischemic stroke